With the analysis among 746 patents, we discovered top 272 key players by total patent application. Pharmacyclics LLC, Redx Pharma Plc, Iovance Biotherapeutics, Inc. are dominant in this area. They take 11.26% of the total patent filing.
California, United States
Patent: 48
Cheshire East, United Kingdom
Patent: 19
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 17
Ortho Pharmaceutical Corp.
New Jersey, United States
Patent: 14
Arena Pharmaceuticals, Inc.
California, United States
Patent: 12
Massachusetts, United States
Patent: 10
Bayern, Germany
Patent: 10
With the analysis among 12 patents, we discovered top 6 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, BostonGene Corp., Hrain Biotechnology Co. Ltd. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Massachusetts, United States
Patent: 2
Hrain Biotechnology Co. Ltd.
Shanghai Shi, China
Patent: 2
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 1
Da Zen Theranostics, Inc.
California, United States
Patent: 1
With the analysis among related 228 patents applied in the last 5 years. We discover 134 most active companies in this area. The fast-growing Iovance Biotherapeutics, Inc., CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd., Borui Biomedical Technology (Suzhou) Co Ltd take 12.72% of patent filing during this period.
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 17
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd.
Hebei Sheng, China
Patent: 6
Borui Biomedical Technology (Suzhou) Co Ltd
Jiangsu Sheng, China
Patent: 6
Arena Pharmaceuticals, Inc.
California, United States
Patent: 6
California, United States
Patent: 5
Cheshire East, United Kingdom
Patent: 5
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 4
Cell Signaling Technology, Inc.
Massachusetts, United States
Patent: 4
Shanghai Tenth People'S Hospital
Shanghai Shi, China
Patent: 4
With the analysis among related 228 patents in last 5 years, we discover 108 new entrants. Iovance Biotherapeutics, Inc., CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd., Borui Biomedical Technology (Suzhou) Co Ltd are the most active new entrants in this area.
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 17
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd.
Hebei Sheng, China
Patent: 6
Borui Biomedical Technology (Suzhou) Co Ltd
Jiangsu Sheng, China
Patent: 6
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 4
The First Affiliated Hospital of Xiamen University
Fujian Sheng, China
Patent: 3
Chengdu Chipscreen Pharmaceutical Ltd.
Sichuan Sheng, China
Patent: 3
Heidelberg Pharma Research GmbH
Nagano-ken, Japan
Patent: 3
Shanghai Cellular Biopharmaceutical Group Ltd.
Shanghai Shi, China
Patent: 3
With the analysis among 187 patents, we discovered top 67 universities and scientific research institutions by total patent application. The Scripps Research Institute, Shanghai Institute of Materia Medica Chinese Academy of Sciences, The Trustees of Columbia University in The City of New York are dominant in this area. They take 11.23% of the total patent filing.
The Scripps Research Institute
California, United States
Patent: 7
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 5
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 4
Zhejiang Sheng, China
Patent: 4
Rutgers State University of New Jersey
New Mexico, United States
Patent: 3
The Pennsylvania State University
Pennsylvania, United States
Patent: 3
Louisiana State University
Louisiana, United States
Patent: 3
University of Massachusetts
Massachusetts, United States
Patent: 3